Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: The intergroup rhabdomyosarcoma study-IV experience - A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group Academic Article uri icon

publication date

  • November 1, 2007